Answer
Feb 03, 2026 - 08:04 AM
Larotrectinib is not considered traditional chemotherapy. It is a targeted therapy that specifically inhibits TRK fusion proteins found in certain cancers. Unlike chemotherapy, which affects many types of rapidly dividing cells, larotrectinib targets cancer cells with specific genetic mutations.
